In order to determine the potential clinical relevance of SEPT9 and SEPT2 genes, we analyzed TCGA RNA-Seq data set of GBM and found that their expression levels were significantly associated with unfavorable survival in patients with GBM (Fig. S1C and S1D). This evidence concerns the gene SEPTIN6 and glioblastoma.